Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.31 |
| ▸ | MAOB | P27338 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29384523 | 1.00 | GAA (0.31) | GAAMAOBNPC1RAB9AMAOA | |
| SCHEMBL227535 | 0.95 | GAA (0.33) | GAAMAOBMAOAHTT | |
| SCHEMBL29370220 | 0.95 | GAA (0.33) | GAAMAOBMAOAHTT | |
| SCHEMBL21583722 | 0.92 | — | — | |
| SCHEMBL21641727 | 0.91 | RXFP1 (0.32) | MAOBMAOARXFP1TP53MAPT | |
| SCHEMBL1973788 | 0.91 | RXFP1 (0.33) | GAANPC1RAB9ARXFP1TP53 | |
| SCHEMBL110871 | 0.89 | GAA (0.37) | GAAMAOBNPC1RAB9AMAOA | |
| SCHEMBL29384951 | 0.89 | GAA (0.37) | GAAMAOBNPC1RAB9AMAOA | |
| SCHEMBL8620062 | 0.88 | NPC1 (0.34) | GAANPC1RAB9AMEN1KMT2A | |
| SCHEMBL2798152 | 0.87 | GAA (0.36) | GAAMAOBNPC1RAB9AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528965-B2 | Active energy curable resin composition, hard coat laminated film, and film for application to glass | RIKEN TECHNOS CORPORATION (JP) | 2026-01-20 | — | — | US | disclosed |
| EP-3578161-B1 | METHOD FOR IMPROVING STORAGE STABILITY OF COSMETIC | ADEKA CORP (JP) | 2025-11-12 | — | — | EP | disclosed |
| US-12429722-B2 | Laminated glass | AGC Inc. (JP) | 2025-09-30 | — | — | US | disclosed |
| EP-3632943-B1 | ACTIVE ENERGY CURABLE RESIN COMPOSITION, HARD COAT LAMINATED FILM, AND FILM FOR APPLICATION TO GLASS | RIKEN TECHNOS CORP (JP) | 2024-10-16 | — | — | EP | disclosed |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | KURARAY CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| CN-117836384-A | Single layer adhesive film and related articles | 3M创新有限公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2024057723-A1 | PHOTOCURABLE COATING COMPOSITION AND COATED ARTICLE | 信越化学工業株式会社 | 2024-03-21 | — | — | WO | disclosed |
| US-11899317-B2 | Laminated glass, and method for manufacturing laminated glass | AGC Inc. (JP) | 2024-02-13 | — | — | US | disclosed |
| WO-2024024613-A1 | COATED ARTICLE AND PRODUCTION METHOD THEREFOR | 信越化学工業株式会社 | 2024-02-01 | — | — | WO | disclosed |
| EP-3763353-B1 | METHOD FOR IMPROVING WATER SOLUBILITY OF SPARINGLY-SOLUBLE COMPONENT | ADEKA CORP (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-20040071998-A1 | Primer composition, coating method, and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-04-15 | — | — | US | disclosed |
| EP-1408082-A2 | Primer composition, coating method, and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-04-14 | — | — | EP | disclosed |
| US-6696515-B2 | PARTIAL CONDENSATE OBTAINED BY SUBJECTING SILANE COMPOUND TO HYDROLYSIS AND PARTIAL CONDENSATION WITH WATER, VINYL POLYMER HAVING UV ABSORBING GROUPS AND HYDROPHILIC GROUPS DISSOLVABLE IN SOLVENT; WEATHER RESISTANCE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-02-24 | — | — | US | disclosed |
| US-6677047-B2 | BENZOTRIAZOLE COMPOUND HAVING A VINYL GROUP MODIFIED THROUGH ITS HYDROXY GROUP WITH A SILANE COMPOUND; TRANSPARENT COATINGS FOR POLYCARBONATE SUBSTRATES WITH MAR, WEATHER, AND CHEMICAL RESISTANCE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-01-13 | — | — | US | disclosed |
| EP-1339113-A1 | PACKAGING MATERIAL FOR ELECTRONIC-PART CASE, AND OTHERS | Showa Denko Packaging Co. (JP) | 2003-08-27 | — | — | EP | disclosed |
| US-20030134951-A1 | Hard protective coat-forming coating compositions and optical articles | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-07-17 | — | — | US | disclosed |
| EP-1327670-A2 | Hard protective coat-forming coating compositions and optical articles | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-07-16 | — | — | EP | disclosed |
| US-20020040094-A1 | Resin composition for coating and coating composition for curing | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-04-04 | — | — | US | disclosed |
| US-20010036986-A1 | Coating composition, coating method, and coated article | KABUSHIKI KAISHA TOYODA JIDOSHOKKI SEISAKUSHO (JP) | 2001-11-01 | — | — | US | disclosed |
| EP-1122278-A2 | Coating composition, coating method, and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | ARL1, ASH2L, VCL | GAA 3590/4885MAOB 3832/4885NPC1 4837/4885 |
| US-12528965-B2 | Active energy curable resin composition, hard coat laminated film, and film for application to glass | MAT2B, MECP2, MNAT1 | GAA 3738/4885MAOB 1847/4885NPC1 4681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.